A 17-year-old female on Aviane (desogestrel/ethinyl estradiol) for three weeks presents with heavy vaginal bleeding and clots; how should this be evaluated and managed?

Management of Heavy Vaginal Bleeding in a 17-Year-Old on Aviane

First, rule out pregnancy and other underlying gynecological problems (STDs, structural pathology, medication interactions, inconsistent pill use), then reassure the patient that breakthrough bleeding during the first 3 months of combined oral contraceptive use is common and generally not harmful—if bleeding persists despite proper pill use and no pathology is found, consider increasing the estrogen dose or switching to an alternative contraceptive method. 1, 2

Initial Evaluation

Rule out critical causes immediately:

• Pregnancy testing is mandatory 2—even with proper Aviane use, pregnancy must be excluded when abnormal bleeding occurs
• Assess medication adherence 1—inconsistent use is a common cause of breakthrough bleeding with combined hormonal contraceptives
• Consider underlying gynecological problems 1:
  • Sexually transmitted infections
  • New pathologic uterine conditions (polyps, fibroids)
  • Drug interactions (particularly enzyme-inducing medications)
  • Cigarette smoking (increases breakthrough bleeding risk)

Understanding the Bleeding Pattern

Breakthrough bleeding during the first 3 months of Aviane use is expected and generally benign 1, 2:

• Unscheduled spotting or bleeding is common during the first 3-6 months of combined hormonal contraceptive use 1
• This bleeding is generally not harmful and typically decreases with continued use 1
• The Aviane FDA label specifically states that "if spotting or breakthrough bleeding occur, the patient is instructed to continue on the same regimen. This type of bleeding is usually transient and without significance" 2

However, persistent or prolonged bleeding requires physician consultation 2—the patient has been bleeding for 3 weeks, which warrants further evaluation.

Management Algorithm

If No Underlying Pathology is Found:

First-line approach: Continue current regimen with reassurance 1, 2

• Most breakthrough bleeding resolves spontaneously within 3-6 months 1
• Emphasize adherence to the prescribed schedule 2
• Ensure pills are taken at the same time daily 2

Second-line medical management if bleeding persists and patient desires treatment 3:

1. Increase estrogen content 3—switch from Aviane (20 mcg ethinyl estradiol) to a 35 mcg ethinyl estradiol formulation
2. Decrease the hormone-free interval 3—reduce from 7 days to 4-5 days in cyclic contraception users
3. Trial of low-dose doxycycline 3—can help stabilize the endometrium

Third-line: Consider alternative contraceptive methods 1

• If bleeding persists and the patient finds it unacceptable, counsel on alternative contraceptive methods 1
• Offer another method if desired 1

Critical Pitfalls to Avoid

Do not discontinue Aviane prematurely 1, 2:

• A hormone-free interval is NOT recommended during the first 21 days of combined hormonal contraceptive use 1
• Stopping the pill may increase pregnancy risk and does not necessarily resolve the bleeding

Do not assume bleeding equals contraceptive failure 2:

• Breakthrough bleeding does not indicate decreased contraceptive effectiveness if pills are taken correctly 2
• The patient should continue taking pills as directed even if bleeding occurs 2

Monitor for signs requiring urgent evaluation 2:

• Severe bleeding requiring pad/tampon change more frequently than every hour
• Signs of anemia (fatigue, dizziness, pallor)
• Severe abdominal pain (could indicate ectopic pregnancy if pregnancy test positive)

Special Considerations for Adolescents

Adolescents may have additional causes of abnormal bleeding 4:

• Anovulatory cycles are common in the teenage years
• Coagulation disorders should be considered in adolescents with heavy menstrual bleeding
• Careful elimination of organic causes is necessary before attributing bleeding solely to the contraceptive 4

Counseling is critical for continuation 5:

• Adolescents have lower continuation rates with all contraceptive methods 5
• Enhanced counseling about expected bleeding patterns improves adherence 1
• Discuss that breakthrough bleeding typically improves after 3-6 months 1

When to Refer

Refer to gynecology if 1:

• Bleeding persists beyond 6 months despite appropriate management
• Structural pathology is suspected or confirmed
• Patient desires definitive evaluation with imaging or endometrial sampling
• Bleeding is severe enough to cause hemodynamic instability or significant anemia